NCT02299609

Ultrasound Beams as an Adjunct to Reperfusion Therapy in STEMI

Therapeutic Effect of Ultrasound Beams as an Adjunct to Reperfusion Therapy in STEMI

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 100 (estimated)
• Sponsor: Sakarya University · Academic / Other
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

Successfully perfused STEMI patients will receive routine transthoracic echocardiography qid for 4 days or placebo. Myocardial function and infarct size will be evaluated at 3 and 6 months.

Detailed description

Patients who had acute STEMI and successfully reperfused by either thrombolytic therapy or primary angioplasty and stenting will be included this study. A basal routine echocardiography will be obtained in all patients after reperfusion therapy. Thereafter, patients will be divided into two groups: 1.Treatment group will receive transthoracic echocardiography using Philips HD11 XE ® for 30 minutes qid for 4 days. 2. Placebo group will have the same Philips HD11 XE ® echo transducer applied for the same time and duration on their chest but with the ultrasound turned-off. Detailed left and right ventricle function as well as performance index and stress-strain imaging will be obtained and analyzed at 3 and 6 months.

Conditions

• Myocardial Infarction
• ST Elevation Myocardial Infarction

Interventions

Type	Name	Description
OTHER	Ultrasound beams Philips HD11 XE®	Ultrasound beams used during standard echocardiography

Timeline

• Start date: 2013-01-01
• Primary completion: 2015-12-01
• Completion: 2016-02-01
• First posted: 2014-11-24
• Last updated: 2014-11-24

Locations

1 site across 1 country: Turkey (Türkiye)